Levels of plasma angiotensin-(1-7) in patients with hypertension who have the angiotensin-I-converting enzyme deletion/deletion genotype

American Journal of Cardiology

Volumn 92, Issue 6, 2003, Pages 749-751

  Jalil, Jorge E ^a   Palomera, Cristián ^b   Ocaranza, María Paz ^b   Godoy, Iván ^b   Román, Maritza ^b   Chiong, Mario ^b   Lavandero, Sergio ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 5; ANGIOTENSIN 6; ANGIOTENSIN 7; ANGIOTENSIN I; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; DIPEPTIDYL CARBOXYPEPTIDASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE DELETION; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; MALE; PATIENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

EID: 0042835819     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00847-6     Document Type: Article

References (17)

1. Ferrario C.M. Does angiotensin-(1-7) contribute to cardiac adaptation and preservation of endothelial function in heart failure? Circulation. 105:2002;1523-1525.
2. Santos R., Campagnole-Santos M., Andrade S. Angiotensin-(1-7) an update . Regul Pept. 91:2000;45-62.
3. Heitsch H., Brovkovych S., Malinski T., Wiener G. Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells. Hypertension. 37:2001;72-76.
4. Ferrario C.M. Angiotensin I, angiotensin II, and their biologically active peptides. J Hypertens. 20:2002;805-807.
5. Chappell M., Pirro N., Sykes A., Ferrario C.M. Metabolism of angiotensin-(1-7) by angiotensin converting enzyme. Hypertension. 31:1998;362-367.
6. Cambien F., Costerousse O., Tiret L., Poirier O., Lecerf L., Gonzales M.F., Evans A., Arveiler D., Cambou J.P., Luc G. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 90:1994;669-676.
7. O'Donnell C.J., Lindpaintner K., Larson M.G., Rao V.S., Ordovas J.M., Schaefer E.J., Myers R.H., Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation. 97:1998;1766-1772.
8. Higaki J., Baba S., Katsuka T. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men the Suita Study . Circulation. 101:2000;2060-2065.
9. Danser A.H.J., Schunkert H. Renin-angiotensin system gene polymorphisms potential mechanisms for their association with cardiovascular diseases . Eur J Pharmacol. 410:2000;303-316.
10. Ocaranza M.P., Piddo A.M., Faúndez P., Lavandero S., Jalil J.E. Angiotensin I-converting enzyme gene polymorphism influences chronic hypertensive response in the rat Goldblatt model. J Hypertens. 20:2002;413-420.
11. Brown N.J., Blais C. Jr, Gandhi S.K. ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol. 32:1998;373-377.
12. Murphey L.J., Gainer J.V., Vaughan D.E., Brown N.J. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation. 102:2000;829-832.
13. Lachurié M.L., Azizi M., Guyene T.T., Alhenc-Geles F., Ménard J. Angiotensin converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or on blood pressure in normotensives. Circulation. 345:1995;2933-2942.
14. Jalil J.E., Piddo A.M., Cordova S., Chamorro G., Braun S., Jalil R., Vega J., Jadue L., Lavandero S., Lastra P. Prevalence of the angiotensin I-converting enzyme insertion/deletion polymorphism, plasma ACE activity and left ventricular mass in normotensive Chilean population. Am J Hypertens. 12:1999;697-704.
15. Jalil J.E., Ocaranza M.P., Piddo A.M., Jalil R. Reproducibility of plasma angiotensin-converting enzyme activity in human subjects determined by fluorimetry with Z-phenylalanine-histidyl-leucine as substrate. J Lab Clin Med. 133:1999;501-506.
16. Danser A.H., van Kats J.P., Admiraal P.J., Derkx F.H., Lamers J.M., Verdouw P.D., Saxena P.R., Schalekamp M.A. Cardiac renin and angiotensins uptake from plasma versus in situ synthesis . Hypertension. 24:1994;37-48.
17. Admiraal P.J., Derkx F.H., Danser A.H., Pieterman H., Schalekamp M.A. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension. 15:1990;44-55.